MRF announces partnership with Communications Award Charity Challenge

29 Jun 2021
MRF announces partnership with Communications Award Charity Challenge
Meningitis Research Foundation (MRF) is excited to announce partnering with the PharmaTimes for the 2021 Communications Awards Charity Challenge.

PharmaTimes communications Awards logoThe challenge will see communications specialists providing marketing and strategic advice on the challenges of defeating meningitis. MRF will benefit directly from the fresh and varied ideas presented, and provide feedback for each entrant on their presentation.

Previous charities involved in the competition have been Austistica and Bowel Cancer UK.

Rob Dawson, Director of Communications, Advocacy and Support for Meningitis Research Foundation said:

"We are delighted to have been chosen for these awards. Against the backdrop of COVID-19, we have secured the first-ever global plan to defeat meningitis, which brings with it a variety of communications challenges. We look forward to hearing from experts in the field as part of this award process to see how effective communications could help see an end to preventable deaths for meningitis."

Healthcare communications agencies can get involved by visiting the PharmaTimes website for more information.
If you have a question or concern about meningitis, contact our support helpline

The MRF Membership and Support team are here for you for any questions you might have about meningitis and septicaemia and their effects on you or your family and friends.

You don’t need to face meningitis and sepsis alone
MRF Chief Executive Vinny Smith explains how we're going to defeat meningitis by 2030.
Give researchers the clues to help defeat meningitis
Give researchers the clues to help defeat meningitis
£160/€190/$214 decodes the genetic information in a sample of meningococcal bacteria. This information helps us to track new forms of meningitis and campaign to introduce new vaccines.
Media contact
Elaine Devine - Director of Advocacy, Communications & Support
Tel: 0333 405 6248